Physician profile
Chad R Westphal
NPI 1720128051
$300,167.88
in general payments reported to CMS, 2019-2025
6 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $29K · 2021: $45K · 2022: $69K · 2023: $51K · 2024: $39K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $121K · Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $120,790.70 |
| Food and Beverage | $407.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $229,578.46 | 2019-2025 | Stratum Foot Plating System, Twistoff Twistoff Screw, Comprehensive Vault Reconstruction System |
| Medartis INC. | $50,668.71 | 2022-2025 | Aptus |
| Nextremity Solutions INC. | $19,497.54 | 2019-2021 | |
| Forthright Medical - Az, LLC | $392.60 | 2024-2025 | Pending, Pending |
| Acera Surgical, INC. | $15.62 | 2019 | |
| Mimedx Group, INC. | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Westphal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.